Top 5 Dividend Stocks To Buy For 2019

Related CMCO 10 Stocks That Rallied For Three Days On Increasing Volume, No News Earnings Scheduled For June 1, 2016
Related CWT Mid-Day Market Update: Eli Lilly Tumbles After Alzheimer's Study Fails To Meet Goals; Euroseas Shares Rise 10 Notable Stocks Trading Ex-Dividend Thursday, November 3

 

Toward the end of trading Wednesday, the Dow traded up 0.23 percent to 19,067.53 while the NASDAQ declined 0.29 percent to 5,370.64. The S&P also fell, dropping 0.05 percent to 2,201.93.

Leading and Lagging Sectors

Wednesday afternoon, industrial shares gained by 0.54 percent. Meanwhile, top gainers in the sector included Deere & Company (NYSE: DE), and Columbus McKinnon Corp. (NASDAQ: CMCO).

In trading on Wednesday, utilities shares fell by 0.75 percent. Meanwhile, top losers in the sector included California Water Service Group (NYSE: CWT), down 7 percent, and MGE Energy, Inc. (NASDAQ: MGEE), down 6 percent.

Top 5 Dividend Stocks To Buy For 2019: Summit State Bank(SSBI)

Advisors’ Opinion:

  • [By Max Byerly]

    ValuEngine upgraded shares of Summit State Bank (NASDAQ:SSBI) from a hold rating to a buy rating in a research note released on Saturday.

    Separately, TheStreet raised Summit State Bank from a c+ rating to a b rating in a report on Wednesday, February 14th.

Top 5 Dividend Stocks To Buy For 2019: 3M Company(MMM)

Advisors’ Opinion:

  • [By ]

    In fact, top dividend-paying companies like Procter & Gamble (NYSE:PG), Johnson & Johnson (NYSE:JNJ), and 3M (NYSE:MMM) have consistently converted 15% or more of their revenues into free cash flows (FCF). Combined, the three companies generated nearly $173 billion in revenues in 2017. That’s a lot of money, and a good chunk of it is going into shareholders’ pockets. That’s why these money-minting dividend stocks deserve your attention.

  • [By Lee Samaha]

    The 16% year-to-date dip in the stock price of 3M Company (NYSE:MMM) is naturally going to attract value investors toward the Dividend Aristocrat. After all, the company now sports a near 2.7% dividend yield, and more than 60 years of dividend increases attest to its history of delivering for investors. However, I think the stock is still worth avoiding. Incoming CEO Mike Roman’s presentation at the recent Electrical Products Group (EPG) conference did little to dispel fears concerning the company’s pricing power — a key part of its business model. Let’s take a look at why, as well as what was discussed at the event.

  • [By Ethan Ryder]

    EP Wealth Advisors LLC increased its stake in 3M Co (NYSE:MMM) by 4.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 83,821 shares of the conglomerate’s stock after acquiring an additional 3,566 shares during the period. 3M makes up approximately 1.8% of EP Wealth Advisors LLC’s investment portfolio, making the stock its 8th biggest position. EP Wealth Advisors LLC’s holdings in 3M were worth $18,400,000 at the end of the most recent reporting period.

  • [By Paul Ausick]

    3M Company (NYSE: MMM) traded down 1.74% at $202.18. The stock’s 52-week range is $191.44 to $259.77. Volume was about 40% below the daily average of around 2.9 million shares. The company had no specific news Tuesday.

  • [By Paul Ausick]

    The second-worst Dow stock so far this year is The Procter & Gamble Co. (NYSE: PG), down 16%; followed by Walmart Inc. (NYSE: WMT), down 14.6%; 3M Company (NYSE: MMM), down 12.3%; and Johnson & Johnson (NYSE: JNJ), down 11.2%. The 30 Dow stocks are evenly split with year-to-date winners and losers each numbering 15.

Top 5 Dividend Stocks To Buy For 2019: CRB Futures Index(CR)

Advisors’ Opinion:

  • [By Shane Hupp]

    DA Davidson set a $111.00 price target on Crane (NYSE:CR) in a research report released on Friday. The brokerage currently has a buy rating on the conglomerate’s stock.

  • [By Shane Hupp]

    BlackRock Inc. grew its stake in Crane Co. (NYSE:CR) by 2.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,303,084 shares of the conglomerate’s stock after acquiring an additional 93,264 shares during the period. BlackRock Inc. owned 7.21% of Crane worth $399,069,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Crew Energy (TSE:CR) insider James A. Taylor acquired 5,000 shares of the stock in a transaction that occurred on Monday, June 18th. The stock was acquired at an average cost of C$2.04 per share, for a total transaction of C$10,200.00.

Top 5 Dividend Stocks To Buy For 2019: Cummins Inc.(CMI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Cummins (NYSE:CMI) had its price objective cut by Credit Suisse Group from $205.00 to $175.00 in a research note released on Wednesday. They currently have an outperform rating on the stock.

  • [By Logan Wallace]

    Traders purchased shares of Cummins Inc. (NYSE:CMI) on weakness during trading on Tuesday after Citigroup lowered their price target on the stock from $160.00 to $150.00. $62.74 million flowed into the stock on the tick-up and $35.34 million flowed out of the stock on the tick-down, for a money net flow of $27.40 million into the stock. Of all equities tracked, Cummins had the 32nd highest net in-flow for the day. Cummins traded down ($0.21) for the day and closed at $133.94

  • [By Jason Hall]

    Furthermore, having a strong financial partner in Total to help it drive adoption of heavy-duty natural gas vehicles at this time could be a huge win. Prices of oil (and therefore diesel) have been steadily climbing over the past year, and the highly anticipated near-zero-emissions natural gas engine fromCummins(NYSE:CMI) andWestport Fuel Systems(NASDAQ:WPRT) is now being shipped to customers.

  • [By ]

    As Caterpillar sank, so too did Cummins Inc. (CMI) , down 4.5%, Cree Inc. (CREE) , down 2.5%, Crane Co. (CR) , down 8% and Freeport McMoRan (FCX) , down 14.5%.

Top 5 Dividend Stocks To Buy For 2019: Laboratory Corporation of America Holdings(LH)

Advisors’ Opinion:

  • [By Shane Hupp]

    These are some of the headlines that may have impacted Accern’s analysis:

    Get LabCorp alerts:

    $2.92 Earnings Per Share Expected for LabCorp (LH) This Quarter (americanbankingnews.com) Global Contract Research Organization Market 2018 Pioneers by 2023: Parexel, LabCorp (Covance), PRA, PPD … (theexpertconsulting.com) OmniSeq and LabCorp Launch OmniSeq Advance? Assay (nasdaq.com) LabCorp’s latest collaboration aims to accelerate personalized, genomic medicine (bizjournals.com) Can Laboratory Corporation of America Holdings (NYSE:LH) Continue To Outperform Its Industry? (finance.yahoo.com)

    LH has been the topic of several analyst reports. Barclays lifted their target price on shares of LabCorp from $195.00 to $210.00 and gave the stock an “overweight” rating in a research note on Monday, February 26th. They noted that the move was a valuation call. Zacks Investment Research raised shares of LabCorp from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a research note on Friday, February 9th. Jefferies Group reaffirmed a “hold” rating and issued a $176.00 target price on shares of LabCorp in a research note on Tuesday, March 6th. ValuEngine raised shares of LabCorp from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Finally, Morgan Stanley lifted their target price on shares of LabCorp from $182.00 to $192.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 28th. Five research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. LabCorp has an average rating of “Buy” and an average target price of $191.06.

  • [By Joseph Griffin]

    Envestnet Asset Management Inc. reduced its position in shares of LabCorp (NYSE:LH) by 45.1% during the first quarter, HoldingsChannel.com reports. The fund owned 19,179 shares of the medical research company’s stock after selling 15,727 shares during the quarter. Envestnet Asset Management Inc.’s holdings in LabCorp were worth $3,116,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Here are some of the headlines that may have impacted Accern Sentiment’s rankings:

    Get Laboratory Corp. of America alerts:

    Stock Traders Buy Large Volume of Laboratory Corp. of America Put Options (LH) (americanbankingnews.com) Credit Suisse Group Lowers Laboratory Corp. of America (LH) to Hold (americanbankingnews.com) Laboratory Corp. of America (LH) Set to Announce Quarterly Earnings on Wednesday (americanbankingnews.com) Can LaunchPad Aid LabCorp's (LH) Covance Arm in Q1 Earnings? (finance.yahoo.com) As Laboratory Corp Of America Holdings (LH) Shares Rose, Shareholder Veritas Investment Management Llp … (djzplanet.com)

    LH has been the subject of several research analyst reports. Craig Hallum restated a “buy” rating and set a $204.00 price target (up from $180.00) on shares of Laboratory Corp. of America in a research note on Wednesday, February 7th. Morgan Stanley upped their target price on Laboratory Corp. of America from $182.00 to $192.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 28th. Zacks Investment Research downgraded Laboratory Corp. of America from a “hold” rating to a “sell” rating in a research report on Wednesday, January 3rd. Mizuho set a $178.00 target price on Laboratory Corp. of America and gave the stock a “hold” rating in a research report on Wednesday, January 24th. Finally, Robert W. Baird set a $183.00 target price on Laboratory Corp. of America and gave the stock a “hold” rating in a research report on Thursday, February 8th. Seven investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $189.19.

  • [By Shane Hupp]

    Laboratory Corp. of America (NYSE: LH) and OpGen (NASDAQ:OPGN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends.

  • [By Max Byerly]

    MUFG Americas Holdings Corp trimmed its stake in LabCorp (NYSE:LH) by 55.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,683 shares of the medical research company’s stock after selling 13,073 shares during the quarter. MUFG Americas Holdings Corp’s holdings in LabCorp were worth $1,728,000 as of its most recent filing with the Securities & Exchange Commission.

Leave a Reply

Your email address will not be published. Required fields are marked *